Written by LVS on Thursday 2 June 2016 in the category news with the tags vision / opinion / people.
The Belgian biotech network just got stronger with the new Walloon incentive Bridge2Health. Formerly known as sCINNAMIC, Bridge2Health (B2H) combines the expertise of the Liège University (ULg) and Liège University Hospital (CHU de Liège) and provides access to a broad platform of healthcare solutions.
As the entry point of successful collaborations, B2H sets up partnerships with industry and academic centers worldwide. B2H’s assistance and services cover everything from preclinical to translational research in various medical fields, phase I clinical trials and medical device development.
Bridge2Health, welcome to the family!